Regulatory Affairs Updates | CW17| qtec-group

Regulatory Affairs Updates 17/20

Medical Devices - Guidelines and Regulations Worldwide


It is done! - As per our last RA news update, the proposal for the MDR postponement was accepted by the parliament and the amending regulation (EU) 2020/561 was even published already in the Official Journal of the European Union today!

MDR – MDCG update

The European commission has published four additional MDCG Guidance documents on 24th of April 2020. Even if the EU MDR might be postponed these Guidance shall be considered by the legal manufacturers immediately.

Also look out for a more detailed analysis of the new guidance in the upcoming week…



The EU commission service has published a working document for Current performance of COVID-19 test methods and devices and proposed performance criteria.

Additionally, the annex I Commercial devices: provides an overview of approved test Kits as well an overview of the regulatory status.

  • ID
  • Source
  • Status
  • Speed
  • Type
  • Immuno-subtype
  • Manufacturer
  • Commercial Name
  • Regulatory Status

APAC Region EUA Information

Several Countries in the APAC Region are still working on an Emergency Use Authorization (EUA) for Products during the COVID-19 pandemic.

Chinese Taipei

List of COVID-19 related EUA on Manufacturing / Import of Medical Device.

Kingdom of Saudi Arabia

Saudi FDA Regulatory requirements for Emergency Use Authorization (EUA) for IVDD and Personal Protective Equipment (PPE) during the outbreak of COVID-19.


1. NMPA gives emergency approvals to COVID-19 test kits.

2. Regulatory Requirements and Standards for Coronavirus Reagent Test Kits and Protective Equipment in China.

Republic of Korea

List of COVID-19 Diagnostic Kits Authorized for Use under Emergency Use Authorizations.

IMDRF Updates

The International Medical Devices Regulatory Forum (IMDRF) has published 4 new documents on 20th of April 2020.

  • IMDRF/CYBER WG/N60FINAL: 2020 Principles and Practices for Medical Device Cybersecurity

This document provides concrete recommendations to all responsible stakeholders on the general principles and best practices for medical device cybersecurity (including in vitro diagnostic (IVD) medical devices) and Employ a risk-based approach to the design and development of medical devices with appropriate cybersecurity protections.

It shall Ensure the safety, performance, and security of medical devices and the connected healthcare infrastructure during the total Product life Cycle (TPLC) and differentiate between Pre-Market Considerations for Medical Device Cybersecurity and Post-Market Considerations for Medical Device Cybersecurity in respect to

  • Design Principle,
  • Secure Communications,
  • Data Protection, Device Integrity,
  • User Authentication, Software Maintenance,
  • Physical Access as well as Reliability and Availability

  • IMDRF/GRRP WG/N59FINAL: 2020 Requirements for Regulatory Authority Recognition of Conformity Assessment Bodies Conducting Medical Device Regulatory Reviews

Terminologies for Categorized Adverse Event Reporting (AER): terms, terminology and codes - PDF (1.21Mb)

Yes we can help you!

Just give us a call / email and over 60 experts are standing ready to offer you assistance and support.

Contact +49 451 808 503 60

All updates compiled in one PDF file:

You can download all Regulatory Affairs Updates compiled for you as a PDF under the following link.

Unser Newsletter „qonzentrat“

kompakt, professionell und präzise

Profitieren Sie von unserem Fachwissen.

Jetzt anmelden